PMID- 27143258 OWN - NLM STAT- MEDLINE DCOM- 20170802 LR - 20220330 IS - 1528-0020 (Electronic) IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 127 IP - 25 DP - 2016 Jun 23 TI - Acquired von Willebrand syndrome associated with left ventricular assist device. PG - 3133-41 LID - 10.1182/blood-2015-10-636480 [doi] AB - Left ventricular assist devices (LVAD) provide cardiac support for patients with end-stage heart disease as either bridge or destination therapy, and have significantly improved the survival of these patients. Whereas earlier models were designed to mimic the human heart by producing a pulsatile flow in parallel with the patient's heart, newer devices, which are smaller and more durable, provide continuous blood flow along an axial path using an internal rotor in the blood. However, device-related hemostatic complications remain common and have negatively affected patients' recovery and quality of life. In most patients, the von Willebrand factor (VWF) rapidly loses large multimers and binds poorly to platelets and subendothelial collagen upon LVAD implantation, leading to the term acquired von Willebrand syndrome (AVWS). These changes in VWF structure and adhesive activity recover quickly upon LVAD explantation and are not observed in patients with heart transplant. The VWF defects are believed to be caused by excessive cleavage of large VWF multimers by the metalloprotease ADAMTS-13 in an LVAD-driven circulation. However, evidence that this mechanism could be the primary cause for the loss of large VWF multimers and LVAD-associated bleeding remains circumstantial. This review discusses changes in VWF reactivity found in patients on LVAD support. It specifically focuses on impacts of LVAD-related mechanical stress on VWF structural stability and adhesive reactivity in exploring multiple causes of AVWS and LVAD-associated hemostatic complications. CI - (c) 2016 by The American Society of Hematology. FAU - Nascimbene, Angelo AU - Nascimbene A AD - Center for Advanced Heart Failure, Health Science Center at Houston, University of Texas, Houston, TX; FAU - Neelamegham, Sriram AU - Neelamegham S AD - Department of Chemical and Biological Engineering, University at Buffalo, the State University of New York, Buffalo, NY; FAU - Frazier, O H AU - Frazier OH AD - Texas Heart Institute, Baylor College of Medicine, Houston, TX; FAU - Moake, Joel L AU - Moake JL AD - Texas Heart Institute, Baylor College of Medicine, Houston, TX; J.W. Cox Laboratory for Biomedical Engineering, Rice University, Houston, TX; FAU - Dong, Jing-Fei AU - Dong JF AD - BloodWorks Northwest Research Institute, Seattle, WA; and Division of Hematology, Department of Medicine, School of Medicine, University of Washington, Seattle, WA. LA - eng GR - R01 HL071895/HL/NHLBI NIH HHS/United States GR - R01 HL077258/HL/NHLBI NIH HHS/United States GR - R01 HL125957/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review DEP - 20160503 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (von Willebrand Factor) SB - IM MH - Heart Failure/surgery MH - Heart Transplantation/adverse effects/instrumentation MH - Heart-Assist Devices/*adverse effects MH - Hemostasis/physiology MH - Humans MH - Thrombosis/etiology MH - Ventricular Dysfunction, Left/physiopathology/*surgery MH - von Willebrand Diseases/*etiology MH - von Willebrand Factor/physiology PMC - PMC4920020 EDAT- 2016/05/05 06:00 MHDA- 2017/08/03 06:00 PMCR- 2017/06/23 CRDT- 2016/05/05 06:00 PHST- 2015/10/14 00:00 [received] PHST- 2016/04/24 00:00 [accepted] PHST- 2016/05/05 06:00 [entrez] PHST- 2016/05/05 06:00 [pubmed] PHST- 2017/08/03 06:00 [medline] PHST- 2017/06/23 00:00 [pmc-release] AID - S0006-4971(20)34432-3 [pii] AID - 2015/636480 [pii] AID - 10.1182/blood-2015-10-636480 [doi] PST - ppublish SO - Blood. 2016 Jun 23;127(25):3133-41. doi: 10.1182/blood-2015-10-636480. Epub 2016 May 3.